Results
2
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ARTEMISMED | ₹261.05 | -8.0% | 48.5% | ₹35.9b | ₹397.33 | PE48.7x | E33.4% | 0.2% | ||
YATHARTH | ₹401.95 | -6.2% | -17.6% | ₹38.7b | ₹560.67 | PE29.8x | E28.4% | n/a |